DALLAS, May 10, 2017 /PRNewswire/ -- Generational Equity, a leading mergers and acquisitions advisor for privately heldbusinesses, is pleased to announce the sale of its client, Safis Solutions LLC, to the PharmaLex Group. The acquisition closed April 7, 2017. Details were not disclosed.
Safis Solutions, headquartered in
"We are delighted to be joining the PharmaLex Group," said Safis Solutions founder Ping Poulsen. "Not only can we expand our breadth and depth of expertise by being part of a global multinational company but a more mature infrastructure will allow us to offer our clients a more comprehensive service portfolio."
PharmaLex, headquartered in Frankfurt, Germany, provides solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology and veterinary medicine.
"The acquisition enables PharmaLex to complement its existing E.U. medical device expertise with high quality and established U.S. medical device capabilities," said Dr. Thomas Dobmeyer, PharmaLex CEO. "It will help establish us as a key provider in the U.S."
Generational Equity Managing Director Douglas Smith and Vice President Ryan Johnson led the deal to a successful close.
"It was very important to Ping Poulsen that Safis Solutions be acquired by a company best able to leverage Safis' expertise and maintain its reputation in major medical and pharmaceutical markets for exceptional ethical and work standards," said lead dealmaker Johnson. "PharmaLex was the perfect fit and offers an exciting opportunity for Safis' employees to be part of a larger multinational company."
About Generational Equity
Generational Equity, part of the Generational Group headquartered in Dallas with over 200 professionals located throughout North America, helps business owners release the wealth of their business by providing merger, acquisition and strategic growth advisory services. Their four-step approach features exit planning education, business valuation, value enhancement strategies, and M&A transactional services. The M&A Advisor recently named the company its 2016 Investment Banking Firm of the Year. For more, visit http://www.generational.com or the Generational Equity press room.
For more information:Carl Doerksen972email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/generational-equity-announces-sale-of-safis-solutions-to-pharmalex-group-300451964.html
SOURCE Generational Equity
Subscribe to our Free Newsletters!
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused ...
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...
Vitamin A is an extremely vital vitamin needed for the eyes, skin, hair, immunity and during ...View All